This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxo Group Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Araceli Mallo-Rubio: A Pioneer in Tuberculosis Treatment
Introduction
Araceli Mallo-Rubio is an innovative inventor based in Madrid, Spain, known for her significant contributions to the field of pharmaceuticals. With a focus on developing effective treatments for tuberculosis, Mallo-Rubio has dedicated her expertise to advancing medical science and enhancing public health.
Latest Patents
Mallo-Rubio holds a patent for "3-amino-pyrazole derivatives useful against tuberculosis." This patent describes a compound of Formula (I) or a pharmaceutically acceptable salt thereof. The structure involves a 5 to 10-membered heteroaromatic ring, with various substitutions making it effective in therapeutic applications. Her work emphasizes the compound's potential in the treatment of tuberculosis and outlines methods for its preparation, showcasing her role in combating this serious health issue.
Career Highlights
Mallo-Rubio has made a name for herself in the pharmaceutical industry, particularly through her association with Glaxo Group Limited. Her research has led to breakthroughs in the treatment of infectious diseases, particularly focusing on the development of novel compounds that address unmet medical needs. With her impressive patent portfolio, she continues to influence the field significantly.
Collaborations
Throughout her career, Mallo-Rubio has collaborated with talented individuals such as Julia Castro Pichel and Raquel Fernandez Menendez. These partnerships highlight the collaborative nature of scientific research, fostering an environment where innovative solutions can be developed.
Conclusion
Araceli Mallo-Rubio stands out as a notable inventor in the realm of pharmaceuticals, particularly for her groundbreaking work in developing compounds to treat tuberculosis. Her patents and collaborations underline her dedication to improving global health through innovation. As research continues to evolve, her contributions remain essential to the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile